Genetic counseling is more cost-effective than gene therapy for rare recessive diseases because genomic analysis costs ~$100 per person (soon less) while the lifetime cost of genetic disease (lost workforce participation, caregiving, medical care) is millions, yielding tenfold+ return on investment and making it a public health no-brainer